Dec 9, 2020 by Jason HawthorneDespite Impressive Headlines, Is Teladoc Diluting Its Future?The telehealth company is expanding at an impressive pace, but investors expecting big stock gains need to be paying attention to per-share metrics.
Dec 8, 2020 by Jason HawthorneBuy, Sell, or Hold TDOC Stock at $200?Two big questions remain unanswered heading into 2021.
Dec 8, 2020 by Jason HawthorneBNTX Stock: Buy at the High?The company's development of a gene-based vaccine should help investors get over a high stock price
Dec 8, 2020 by Jason HawthorneDid You Miss Out on a 5000% Gain With Trillium Stock?A new CEO and prioritization of research could have more big gains in store for the company
Dec 8, 2020 by Jason HawthorneWhen a COVID-19 Vaccine Is Ready, This Company Is Prepared for ActionOne medical distribution company has been through this before.
Dec 8, 2020 by Jason HawthorneHow You Can Profit From the Best-Managed Drugmaker on EarthOne metric shows that decades of dominance treating diabetes has created unrivaled profitability.
Dec 6, 2020 by Jason Hawthorne3 Top Healthcare Stocks to Buy Right NowThese companies have growth opportunities that will last long after the COVID vaccine gets life back to normal.
Dec 5, 2020 by Jason HawthorneThe Surprising Stock That Had a Coronavirus BoostAfter initially struggling with the pandemic, digital tools helped this company get back on track and reach record sales.
Dec 5, 2020 by Jason HawthorneIs It Too Late to Buy Moderna Stock?It's not too late if you think the success of the company's COVID-19 vaccine can translate to other programs in its pipeline.
Dec 5, 2020 by Jason HawthorneDid Google's DeepMind Just Revolutionize Medicine?I'm not sure that drug discovery will ever be the same.
Dec 5, 2020 by Jason HawthorneNew Coronavirus Tests Have These Diagnostics Companies RecalibratingThe COVID-19 testing landscape is changing. Will that sap the growth of the incumbent leaders?
Dec 3, 2020 by Jason HawthorneThe COVID Vaccine Rollout Will Be a Boon for These 2 Beaten-Down StocksThe nation's two largest drugstore operators are about to get a much-needed shot in the arm -- while giving out millions of them for free.
Dec 1, 2020 by Jason HawthorneIs Novavax Stock a Buy?How much opportunity will exist for the company's vaccines by the time they are on the market?
Nov 29, 2020 by Jason HawthorneWhy AstraZeneca's Potential Vaccine Is More Exciting Than You ThinkInvestors are missing the big picture in the drugmaker's vaccine announcement.
Nov 28, 2020 by Jason HawthornePfizer's Vaccine Candidate Is Effective -- But It Has IssuesThe company's offering presents challenges at every step from the lab to the syringe.
Nov 28, 2020 by Jason HawthorneGilead's New CEO Is Going All-In on AcquisitionsDaniel O'Day has made increasingly larger deals in an effort to improve the company's portfolio of cancer drugs.
Nov 27, 2020 by Jason HawthornePet Ownership Is Booming. Could These 3 Stocks Help You Profit?Americans treat pets like family members, and that includes spending on specialty food, health services, and insurance.
Nov 27, 2020 by Jason HawthorneIs This Coronavirus Treatment Setting Investors Up for Failure?Big shot organizations are recommending against the use of Gilead's antiviral to treat COVID-19.
Nov 26, 2020 by Jason HawthorneThis Biotech Is Up 1,500% This Year. Can It Make You Rich in 2021?Investors are catching on to the opportunity for this innovative cancer therapy, and so is big pharma.
Nov 25, 2020 by Jason Hawthorne3 Stocks to Buy for the Comeback From the CoronavirusWith safe and efficacious vaccines just on the horizon, these healthcare stocks will get a boost as life returns to normal.
